查询词典 treated

There were, 20 cases treated with non-surgical therapy; 20 cases treated with simple splenorrhaphy, 48 cases with ligation of splenic artery, splenorrhaphy and/or partial splenectomy, 20 treated with splenectomy and autologous spleen transplantation, and 100 cases with simple splenectomy.

其中非手术治疗20例；采用保脾手术治疗88例，包括20例单纯脾修补，48例施以脾动脉结扎和／或脾部分切除和／或脾修补术，20例脾切除术后自体脾移植；100例脾门及附脾多处破裂者行脾切除术。

Results Patients who had at least one abnormal result of liver function test accounted for 70.99% in untreated group and 61.07% in treated group. The most common abnormal hepatic function parameter in patients with thyrotoxic hepatic lesion was increased alkaline phosphate enzyme, which was 57.3% in untreated group and 51.0% in treated group. Abnormalities of alanine transaminase, aspartate transaminase, gamma-glutamyl tyanspeptidase and total bilirubin were 28.2%(37/131), 18.3%(24/131), 10.7%(14/131) and 21.4%(28/131) in untreated group and 21.5%(32/149), 15.4%(23/148), 4.7%(7/149) and 20.1%(30/149) in treated group, respectively. The possibility of thyrotoxic hepatic dysfunction was correlated with the patients' age and FT3 and FT4 levels, but not with the genesis and course of disease, sex, family history of hyperthyroidism, or levels of TGAb and TMAb. Conclusion Abnormal results of liver function test are commom in patients with hyperthyroidism.

结果 在未治组甲亢性肝功能损害的发生率为70.99%，经治组为61.07%；甲亢性肝功能损害最常见的异常指标是碱性磷酸酶增高，未治组、经治组分别为57.3%、51.0%；血清谷丙转氨酶异常在两组的发生率分别为28.2%、21.5%；血清谷草转氨酶异常在两组的发生率分别为18.3%、15.4%；总胆红素异常在两组的发生率分别为21.4%、20.1%；谷酰胺转肽酶异常的发生率未治组和经治组分别为10.7%、4.7%；甲亢性肝功能损害的发生与病程、甲状腺疾病家族史、性别、TGAb水平、TMAb水平无关，与年龄、甲状腺激素水平有关。

Methods:106 patients were randomly into two group treated with laser,66 patients were treated with Ultrapuilse 5000c CO 2 laser and 40 patients treated with potasium titanyl phosphatelaser,and the clinical effect were evaluated.

为了观察不同波长激光对疗效的影响，于 1999年 8月-2 0 0 1年 8月，我们对10 6例鼻little氏区出血的门诊患者分别采用超脉冲CO2 激光和倍频Nd ：YAG激光二种方法进行止血治疗。

Methods 180patients with liver injury owed to various pathogeny were randomly divided into3groups,which were control group A treated with hepatocyte growth-promoting factors,control group B treated with hepatocyte growth-promoting factors and Jinshuangqi,and treatment group treated with hepatocyte growth-promoting factors,Jinshuangqi and Tongkang tablet.

应用随机对照方法，将不同病因引起的180例转氨增高患儿分成3组，分别为促肝细胞生长素组、金双歧联用促肝细胞生长素组和促肝细胞生长素、金双歧和童康片三药联用组。

Methods 180patients with liver injury owed to various pathogeny were randomly divided into3groups,which were control group A treated with hepatocyte growth-promoting factors,control group B treated with hepatocyte growth-promoting factors and Jinshuangqi,and treatment group treated with hepatocyte growth-promoting factors,Jinshuangqi and Tongkang tablet.

应用随机对照方法，将不同病因引起的180例转氨酶增高患儿分成3组，分别为促肝细胞生长素组、金双歧联用促肝细胞生长素组和促肝细胞生长素、金双歧和童康片三药联用组。

And Toona sinensis were steam-treated at temperature 70℃ and 90℃ for 4 h and 8 h. The radial gas permeability and tangential gas permeability of the steam-treated specimens were compared with those of non-steam-treated one.

处理条件为：杉木和马尾松木材的汽蒸温度分别为90、100℃，假水青冈和香椿木材的汽蒸温度分别为70、90℃，处理时间分别为4 h和8 h，并对汽蒸处理前后木材的弦向和径向气体渗透性分别进行了测定。

Based on an intention-to-treat analysis, patients treated with pioglitazone had a significant increase in limb fat compared with those receiving placebo (0.38 vs 0.05 kg; P =.051). No difference was found, however, in the patients treated with stavudine. After excluding these patients, the increased limb fat was even greater for the pioglitazone-treated patients (0.45 vs 0.04 kg; P =.013). Other improvements included increased thigh circumference (1.4 vs 0.2 cm; P =.017) and tricipital skin-fold thickness (0.9 mm vs 0.4 mm; P =.047). No difference was found in subcutaneous abdominal fat or visceral fat.

根据意向分析，接受pioglitazone治疗相较于接受安慰剂的病患，肢体脂肪显著地增加（0.38相较于0.05公斤；P＝。051）；除了使用stavudine治疗的病患外，并没有发现差异；在排除这些病患后，接受pioglitazone治疗的病患，肢体脂肪显著地增加（0.45公斤比0.04公斤；P＝。013）；其它变化包括大腿围增加（1.4相较于0.2公分；P＝。017），以及三头肌皮肤厚度（0.9公厘相对于0.4公厘；P＝。047），至于皮下脂肪或是脏器脂肪并没有差异。

Based on an intention-to-treat analysis, patients treated with pioglitazone had a significant increase in limb fat compared with those receiving placebo (0.38 vs 0.05 kg; P =.051). No difference was found, however, in the patients treated with stavudine. After excluding these patients, the increased limb fat was even greater for the pioglitazone-treated patients (0.45 vs 0.04 kg; P =.013). Other improvements included increased thigh circumference (1.4 vs 0.2 cm; P =.017) and tricipital skin-fold thickness (0.9 mm vs 0.4 mm; P =.047). No difference was found in subcutaneous abdominal fat or visceral fat.

根据意向分析，接受pioglitazone治疗相较於接受安慰剂的病患，肢体脂肪显著地增加（0.38相较於0.05公斤；P＝。051）；除了使用stavudine治疗的病患外，并没有发现差异；在排除这些病患后，接受pioglitazone治疗的病患，肢体脂肪显著地增加（0.45公斤比0.04公斤；P＝。013）；其他变化包括大腿围增加（1.4相较於0.2公分；P＝。017），以及三头肌皮肤厚度（0.9公厘相对於0.4公厘；P＝。047），至於皮下脂肪或是脏器脂肪并没有差异。

Result:Of four patients with CSF leakage treated by endonasal endoscopic repair,three were cured and one were improvement;Ten of twele cases treated by Supratentorial caniotomy repair were cured,the left were improvement;The left fifteen patients were conservatively treated,two were cured,eleven were improvement,two were unrecovered.

结果：4例经鼻内镜下修补术，愈合3例，好转1例；12例行幕上开颅修补术，愈合10例，好转1例，未愈1例；余15例给予保守治疗，治愈2例，好转11例，未愈2例。

Results The succeed rate of ESWL by one time was 85%, 12 cases were treated by second time with ESWL ,16 cases were treated by cutting open ureteral orifice with cystoscopy, 3 cases were treated by ureterolithotomy.

结果 一次性碎石成功率为85%（187/220），12例行二次碎石，16例行输尿管口扩张剪开术，3例行输尿管切开取石术。

On the other hand, the more important thing is because the urban housing is a kind of heterogeneity products.

另一方面，更重要的是由于城市住房是一种异质性产品。

Climate histogram is the fall that collects place measure calm value, cent serves as cross axle for a few equal interval, the area that the frequency that the value appears according to place is accumulated and becomes will be determined inside each interval, discharge the graph that rise with post, also be called histogram.

气候直方图是将所收集的降水量测定值，分为几个相等的区间作为横轴，并将各区间内所测定值依所出现的次数累积而成的面积，用柱子排起来的图形，也叫做柱状图。